PubMed · 2019 · 16 citations · 18 references
Open access
MedicineNuclear MedicineOncologyMolecular ImagingMolecular OncologyTumor MicroenvironmentLigand BindingOncologic Nuclear ImagingPancreatic CancerTargeted Imaging AgentsTargeting LigandsTumor Receptor ImagingCancer Targeting LigandsMolecular Imaging Probe DesignMolecular Targeting LigandsOncologic Pet ImagingPancreatic Cancer DetectionPet TracersTumor Targeting LigandsTumor-targeted Ligands
Ga-NOTA) is able to clearly delineate the PaCa tumors with a size of 10 mm or less with minimal background noise in normal tissues, including the liver. Substantial tumor uptake is still visible at 2 hr post-injection. The results suggest that the ZD2 peptide targeted PET probe has a potential for sensitive molecular imaging of EDB-FN and early detection of pancreatic cancer to improve healthcare of the patients diagnosed with the disease.
18
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text